MYDA Advisors LLC - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 38 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 42.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
MYDA Advisors LLC ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2022$90,000
+21.6%
150,0000.0%0.04%
+100.0%
Q2 2022$74,000
-45.2%
150,0000.0%0.02%
-60.4%
Q1 2022$135,000
-28.9%
150,000
-11.8%
0.05%
+3.9%
Q4 2021$190,000
-54.8%
170,000
-28.0%
0.05%
-56.8%
Q3 2021$420,000
-39.7%
236,165
+11.8%
0.12%
-32.2%
Q2 2021$697,000
+4.0%
211,165
+5.6%
0.17%
-6.5%
Q1 2021$670,000
+737.5%
200,000
+1900.0%
0.19%
+332.6%
Q3 2018$80,000
-59.0%
10,000
-54.3%
0.04%
-49.4%
Q2 2018$195,00021,9000.08%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,017,971$2,066,0000.49%
DAFNA Capital Management LLC 117,682$239,0000.08%
Temasek Holdings (Private) Ltd 1,422,475$2,888,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 415,450$843,0000.02%
Virtu Financial LLC 54,386$110,0000.01%
MARSHALL WACE, LLP 96,095$195,0000.00%
UBS Group AG 150$00.00%
DEUTSCHE BANK AG\ 2,151$4,0000.00%
MORGAN STANLEY 18,582$37,0000.00%
BANK OF MONTREAL /CAN/ 10,000$20,0000.00%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders